HENRY FORD HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $130.5M
- Transactions
- 14,053
- Companies
- 40
- Average per transaction
- $9,287
Who reported the payments
| Merck | $19,080,982 |
| Modernatx, Inc. | $15,033,519 |
| Pfizer | $7,648,401 |
| Janssen Research & Development, LLC | $5,279,043 |
| Edwards Lifesciences | $5,228,681 |
| Gilead | $4,851,577 |
| Genentech, Inc. | $4,785,511 |
| Abbott | $4,674,577 |
| AbbVie | $3,482,982 |
| Beckman Coulter, Inc. | $3,118,694 |
| AstraZeneca | $3,079,176 |
| Abiomed | $3,003,289 |
| Amgen | $2,448,900 |
| Novartis | $2,359,291 |
| Siemens Medical Solutions USA, Inc. | $2,292,523 |
| Seagen Inc. | $2,263,331 |
| Boston Scientific | $2,109,799 |
| Theratechnologies Inc. | $1,874,431 |
| Astrazeneca UK Limited | $1,869,689 |
| Incyte Corporation | $1,859,267 |
| Eli Lilly | $1,843,295 |
| E.r. Squibb & Sons, L.L.C. | $1,659,179 |
| Medtronic | $1,535,305 |
| Daiichi Sankyo Inc. | $1,319,617 |
| Regeneron | $1,102,070 |
| Lilly USA, LLC | $905,654 |
| Varian Medical Systems, Inc. | $831,816 |
| Bristol Myers Squibb | $800,954 |
| Transmedics, Inc. | $726,446 |
| Viewray Technologies Inc | $708,339 |
| Sanofi US Services Inc. | $699,721 |
| Chiesi USA, Inc. | $652,401 |
| Roche TCRC, Inc. | $589,907 |
| Biogen | $568,349 |
| Astellas Pharma Global Development | $566,344 |
| Roche Molecular Systems, Inc. | $489,937 |
| United Therapeutics Corporation | $485,882 |
| Takeda Pharmaceuticals U.S.A., Inc. | $477,684 |
| Roche Diagnostics Corporation | $471,252 |
| EMD Serono, Inc. | $441,236 |